We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Flow Cytometry Rapidly Determines Specific Interleukin-6 Activity

By LabMedica International staff writers
Posted on 29 Oct 2014
The measurement of the specific activity of a given cytokine often requires a time-consuming and tedious bioassay based upon its effect on the proliferation, chemotaxis, or toxicity of a factor-dependent cell line.

The determination of the specific activity of the cytokine interlukin-6 (IL-6) was accomplished by ascertaining the dose–response curve of the phosphorylation of a signaling protein that can be quantified by flow cytometry.

Immunologists at Héma-Québec (Montreal, QC, Canada) used the IL-6 model, as an approach for the determination of the specific activity of cytokines by determining the dose–response curve of the phosphorylation of the signaling protein Stat-3 pY705 for IL-6, in a responsive cell line subjected to different concentrations of the cytokine. More...
The phosphorylation of the protein is quantified by flow cytometry. Since the signaling cascade only takes a few minutes to achieve following linking of the cytokine to its receptor, the whole procedure can be done in a few hours.

The scientists used the cell line 7TD1 (DSMZ, German Collection of Microorganisms and Cell Cultures GmbH; Braunschweig, Germany), which is an IL-6 dependent cell line. The cells were cultured in RPMI-1640 containing 5% fetal bovine serum (FBS) and 10 ng/mL of IL-6. To speed up flow cytometry, the samples were fluorescently barcoded by adding Pacific Blue and Alexa Fluor 488 to allow multiplex analysis. After processing the cells were analyzed on a Partec CyFlow ML flow cytometer (Swedesboro, NJ, USA).

The scientists were able to determine and compare the specific activity of commercial lots of IL-6 using the flow cytometry method. They observed significant differences both from lots from different manufacturers and lots from a same manufacturer, with an eightfold difference between the specific activity of the highest and lowest one. This demonstrated that in studies requiring accurate cytokine concentrations, determining the specific activity for each lot should be a crucial step in order to get reproducible results.

Higher levels of IL-6 have been observed in the blood of advanced or metastatic cancer patients and are associated with the development of encephalitis in children. The study was published on October 5, 2014, in the Journal of Immunological Methods.

Related Links:

Héma-Québec
German Collection of Microorganisms and Cell Cultures GmbH 
Partec



Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.